Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$256,672
+$34,833 QoQ
Shares Held
1,020
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#3,762
of 4,150 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOWER TRUST & INVESTMENT Co holds $5,569,315 across 10 Drug Manufacturers - General names. ABBV ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,757 | $1,208,135 | |
| 2 | GSK |
GSK plc
|
22,861 | $1,198,373 | |
| 3 | LLY |
ELI LILLY & Co
|
992 | $1,189,834 | |
| 4 | BIIB |
Biogen Inc.
|
2,818 | $608,857 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
10,147 | $584,670 | |
| 6 | PFE |
Pfizer Inc
|
18,965 | $456,677 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
1,020 | $256,672 | |
| 8 | MRK |
Merck & Co., Inc.
|
468 | $60,138 |
All Filings in ABBV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $256,672 | 1,020 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $221,839 | 1,020 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $233,059 | 1,020 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $162,078 | 700 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $129,934 | 700 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $146,664 | 700 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||